<?xml version="1.0" encoding="UTF-8"?>
<p id="Par47">Oseltamivir (Tamiflu) is the most commonly prescribed oral drug used in seasonal influenza and swine flu infections, which is highly effective for decreasing otitis media incidence in children aged between 1–3 years, when treatment is started within 12 h of onset of symptoms [
 <xref ref-type="bibr" rid="CR79">79</xref>]. Some side effects of drugs have also been reported from various studies. A cross-sectional study in the United Kingdom reported that 18% of children with oseltamivir treated with influenza A had mild neuropsychiatric side effects and one or more subsequent symptoms such as not being able to concentrate precisely, insomnia, feeling confused nightmares and acting strangely [
 <xref ref-type="bibr" rid="CR80">80</xref>]. Another study reported frequent vomiting in oseltamivir-treated children as compared to placebo [
 <xref ref-type="bibr" rid="CR81">81</xref>].
</p>
